metricas
covid
Medicina Clínica (English Edition) Should immediate lymphadenectomy be discontinued in patients with metastasis of ...
Journal Information
Vol. 150. Issue 8.
Pages 323-326 (April 2018)
Vol. 150. Issue 8.
Pages 323-326 (April 2018)
Special article
Should immediate lymphadenectomy be discontinued in patients with metastasis of a melanoma in the sentinel lymph node? Report of the results of the Multicenter Selective Lymphadenectomy Trial-II
¿Debe abandonarse la disección ganglionar inmediata en el paciente con metástasis de melanoma en el ganglio centinela? A propósito de los resultados del Multicenter Selective Lymphadenectomy Trial-II
David Moreno-Ramíreza,
Corresponding author
dmoreno@e-derma.org

Corresponding author.
, Sergi Vidal-Sicartb, Susana Puiga, Josep Malvehya
a Unidad de Melanoma, Servicio de Dermatología, Hospital Clínic, Barcelona, Spain
b Servicio de Medicina Nuclear, Hospital Clínic, Barcelona, Spain
Article information
Full Text
Bibliography
Download PDF
Statistics
Tables (2)
Table 1. Frequency of metastatic localizations in the analysis by protocol of the Multicenter Selective Lymphadenectomy Trial-II.
Tables
Table 2. Lymph node recurrence and regional control in the intention-to-treat analysis of the Multicenter Selective Lymphadenectomy Trial-II.
Tables
Show moreShow less

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools